DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,042 filers reported holding DANAHER CORPORATION in Q1 2016. The put-call ratio across all filers is 0.83 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $2,528,000 | +28.6% | 19,148 | +0.4% | 0.04% | +14.7% |
| Q4 2018 | $1,966,000 | -2.1% | 19,069 | +3.2% | 0.03% | +9.7% |
| Q3 2018 | $2,008,000 | +141.9% | 18,479 | +119.7% | 0.03% | +121.4% |
| Q2 2018 | $830,000 | +16.6% | 8,411 | +15.7% | 0.01% | +7.7% |
| Q1 2018 | $712,000 | +1.4% | 7,272 | -3.9% | 0.01% | -7.1% |
| Q4 2017 | $702,000 | +19.4% | 7,566 | +10.3% | 0.01% | +27.3% |
| Q3 2017 | $588,000 | -11.2% | 6,857 | -12.6% | 0.01% | -15.4% |
| Q2 2017 | $662,000 | +8.7% | 7,847 | +10.1% | 0.01% | 0.0% |
| Q1 2017 | $609,000 | -3.3% | 7,125 | -12.0% | 0.01% | -7.1% |
| Q4 2016 | $630,000 | +1.3% | 8,094 | +1.9% | 0.01% | -6.7% |
| Q3 2016 | $622,000 | -6.0% | 7,941 | +21.2% | 0.02% | -6.2% |
| Q2 2016 | $662,000 | +29.0% | 6,550 | +21.1% | 0.02% | +33.3% |
| Q1 2016 | $513,000 | +13.2% | 5,409 | +10.9% | 0.01% | 0.0% |
| Q4 2015 | $453,000 | +44.7% | 4,877 | +32.8% | 0.01% | +33.3% |
| Q3 2015 | $313,000 | – | 3,672 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 232,593 | $60,115,000 | 16.52% |
| Defender Capital, LLC. | 139,231 | $35,988,000 | 14.10% |
| Third Point | 2,700,000 | $697,383,000 | 12.60% |
| Riverstone Advisors, LLC | 62,416 | $16,121,000 | 10.38% |
| Eos Focused Equity Management, L.P. | 32,304 | $8,344,000 | 9.87% |
| Alphinity Investment Management Pty Ltd | 1,185,235 | $306,134,000 | 9.81% |
| AGF Investments America Inc. | 88,205 | $22,782,000 | 8.41% |
| Front Street Capital Management, Inc. | 117,802 | $30,427,000 | 7.70% |
| CORTLAND ASSOCIATES INC/MO | 164,142 | $42,396,000 | 7.55% |
| THAMES CAPITAL MANAGEMENT LLC | 57,156 | $14,763,000 | 7.33% |